U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607015) titled 'CGM Experience, Preferences & Blood Glucose Parameters' on May 19.
Brief Summary: This is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with diabetes and healthcare professionals. Patients will use Instara- 1 and will be followed up to assess device experience, glucose parameters, and diabetes-related quality of life. Healthcare professionals will evaluate device experience and preference, including comparison with F...